Want to see ADMT full AI Analyst Report?
ADMT Stock Chart & Stats
$0.11
<$0.01(7.34%)
At close: 4:00 PM EST
$0.11
<$0.01(7.34%)
Day’s Range― - ―
52-Week Range$0.04 - $0.12
Previous CloseN/A
Volume530.00
Average Volume (3M)13.49K
Market Cap
$3.38M
Enterprise Value$5.34M
Total Cash (Recent Filing)$298.73K
Total Debt (Recent Filing)$911.55K
Price to Earnings (P/E)―
Beta0.18
Next Earnings
Jul 20, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding67,588,490
10 Day Avg. Volume10,740
30 Day Avg. Volume13,493
Financial Highlights & Ratios
PEG Ratio0.47
Price to Book (P/B)7.02
Price to Sales (P/S)1.47
P/FCF Ratio472.30
Enterprise Value/Market Cap1.58
Enterprise Value/Revenue1.57
Enterprise Value/Gross Profit4.06
Enterprise Value/Ebitda35.12
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Improving Cash GenerationSustained positive operating and free cash flow (~$438k TTM) provides durable internal funding for working capital, product builds and R&D without constant external financing. If maintained, this improves resilience, supports reinvestment and reduces liquidity risk over months.
Strong Revenue Growth & MarginsVery strong TTM top-line growth combined with sustained gross margins near the high-30% range indicate structural demand and pricing power in core contract manufacturing. This margin profile helps absorb SG&A and lever fixed costs as scale increases, aiding durable profitability.
Diversified Business ModelA two-pronged model—contract manufacturing with per-unit/project revenue plus a medical tech commercialization pipeline—creates complementary revenue streams. Manufacturing generates recurring cash while medical projects offer longer-term upside, reducing single-source risk structurally.
Bears Say
Fragile ProfitabilityOperating results remain below break-even with negative EBIT and only slightly negative net margin. Without sustained operating profitability, the company remains vulnerable to cost shocks and cannot reliably self-fund growth; structural earnings quality is still unproven.
Balance-Sheet ConstraintsAlthough leverage has improved, the business still carries elevated debt relative to its modest equity base. For a small company this constrains financial flexibility, raises refinancing and interest risks, and limits capacity to absorb setbacks or fund large commercialization investments.
Cash-Flow Consistency RiskHistoric swings from negative to positive cash flow signal execution and working-capital sensitivity. The recent FCF improvement is positive but not yet proven durable; reversal would quickly pressure liquidity and the company’s ability to fund operations or medical commercialization long term.
ADM Tronics Un News
ADMT FAQ
What was ADM Tronics Unlimited Inc’s price range in the past 12 months?
ADM Tronics Unlimited Inc lowest stock price was $0.04 and its highest was $0.12 in the past 12 months.
What is ADM Tronics Unlimited Inc’s market cap?
ADM Tronics Unlimited Inc’s market cap is $3.38M.
When is ADM Tronics Unlimited Inc’s upcoming earnings report date?
ADM Tronics Unlimited Inc’s upcoming earnings report date is Jul 20, 2026 which is in 18 days.
How were ADM Tronics Unlimited Inc’s earnings last quarter?
ADM Tronics Unlimited Inc released its earnings results on Feb 13, 2026. The company reported -$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.002.
Is ADM Tronics Unlimited Inc overvalued?
According to Wall Street analysts ADM Tronics Unlimited Inc’s price is currently Overvalued.
Does ADM Tronics Unlimited Inc pay dividends?
ADM Tronics Unlimited Inc does not currently pay dividends.
What is ADM Tronics Unlimited Inc’s EPS estimate?
ADM Tronics Unlimited Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ADM Tronics Unlimited Inc have?
ADM Tronics Unlimited Inc has 67,588,490 shares outstanding.
What happened to ADM Tronics Unlimited Inc’s price movement after its last earnings report?
ADM Tronics Unlimited Inc reported an EPS of -$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of ADM Tronics Unlimited Inc?
Currently, no hedge funds are holding shares in ADMT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
ADM Tronics Unlimited Inc
ADM Tronics Unlimited, Inc. (ADMT), established in 1969 and headquartered in Northvale, New Jersey, is a company that develops, manufactures, and markets electronic solutions. Its products are primarily designed for non-invasive medical applications, though they also serve other industries, with sales reaching the United States, Australia, Asia, and Europe. The company structures its business across three main divisions: Electronics, Chemical, and Engineering. Within its Electronics segment, ADMT creates specialized devices essential for diagnosing and treating both humans and animals, alongside providing electronic control systems for spas and hot tubs. The Chemical division offers a broad spectrum of water-based products, including primers, adhesives, coatings, resins, and chemical additives. This segment also manufactures anti-static conductive paints, coatings, and related items. Furthermore, it produces water-based, adhesive topical formulations for maxillofacial prosthetic medical applications, as well as for professional makeup artistry, especially in film, television, and theatrical settings. Finally, the Engineering segment delivers extensive services encompassing research, development, and regulatory support. These services are vital for the design, development, and manufacturing of medical devices, various electronic systems, and other advanced technologies and products, including those related to medical electronic therapeutic technology.
Technical Analysis
Ownership Overview
―
Insiders
―
Mutual Funds
0.12% Other Institutional Investors
99.88% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---

